Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Buy
1,742
+12
+0.7% +$1.41K 0.09% 60
2026
Q1
$208K Buy
+1,730
New +$200K 0.09% 54
2025
Q2
Sell
-2,932
Closed -$263K 60
2025
Q1
$263K Buy
+2,932
New +$274K 0.13% 47

Other funds holding MRK

Brogan Financial's MRK Position: Q2 2026 in Review

Brogan Financial increased its Merck (MRK) stake by 0.69% in Q2 2026, buying an estimated $1.41K and bringing the position to 1,742 shares worth $224K. The position accounts for 0.09% of the portfolio, ranked #60.

Brogan Financial first reported a position in MRK in Q1 2025 and has held it in 3 quarters since. The position peaked at $263K in Q1 2025. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Brogan Financial held 1,742 shares of Merck worth $224K as of Q2 2026.
  • Brogan Financial bought 12 Merck shares in Q2 2026, an estimated $1.41K.
  • Merck made up 0.09% of Brogan Financial's portfolio in Q2 2026, its #60 holding.
  • Brogan Financial first reported a position in Merck in Q1 2025 and has held it in 3 quarters since.
  • Brogan Financial's Merck position peaked at $263K in Q1 2025.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Brogan Financial's 13F filing for Q2 2026, filed 13 Aug 2026.